Strategic Growth Target mid-market and emerging growth companies in life sciences, technology, and Israel-focused clients, leveraging the firm’s niche strengths in corporate, IP, and regulatory work revealed by recent oncology transactions and cross-border capabilities.

Transaction Momentum Capitalize on ongoing deal activity such as Regor Pharmaceuticals collaboration with Genentech to position CTSW as a preferred counsel for complex financing, licensing, and M&A (biotech/pharma) transactions.

Boutique Scale Strength Promote the firm’s value proposition of large-firm experience with personal client contact to attract mid-sized clients seeking cost-efficient, senior-led transactional and litigation support across corporate, IP, tax, and restructuring.

Cross-Border Expertise Leverage capabilities in Israel and international matters to target companies with global supply chains or cross-border IP and regulatory needs, offering integrated solutions across jurisdictions.

Digital Readiness Highlight technology-forward service delivery and secure cloud-based workflows to attract tech-enabled clients, while promoting efficiency in handling complex cases through the firm’s modern tech stack and security posture.